Leiden, The Netherlands, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced presentations at upcoming investor conferences. Hans GCP Schikan, Chief Executive Officer, will present a corporate overview at the BioCentury NewsMakers conference in New York, NY on Friday, September 27th, at 10:30am ET and will also participate on a Fireside Chat at the Leerink Rare Disease Roundtable in New York, NY on Tuesday, October 2 nd, at 8:00am ET. A live webcast of the BioCentury presentation can be accessed through the Investor section of the Prosensa corporate website at http://ir.prosensa.eu/events.cfm and will be archived for 90 days.
About Prosensa Holding N.V.
Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. www.prosensa.com
CONTACT: Prosensa Holding N.V. Celia Economides, Director IR & Corporate Communications Phone: +1 917 941 9059 Email: firstname.lastname@example.org
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts